Literature DB >> 19555311

Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study.

Mark Peyrot1, Soren E Skovlund, Ruediger Landgraf.   

Abstract

OBJECTIVE: This study examined the epidemiology of worry about weight among adults with diabetes and whether this weight worry was associated with worse quality of life and diabetes self-management. RESEARCH DESIGN AND METHODS: Participants were 5088 adults with type 1 or type 2 diabetes from the multi-national DAWN study. Random samples of approximately 500 were obtained from each of 11 countries/regions in Asia, Australia, Europe, and North America. All measures were self-reported data obtained during structured interviews. High weight worry was represented by the highest level of agreement with the statement 'I feel very anxious about my weight.'
RESULTS: One-quarter (25.1%) of respondents reported high weight worry. Using multivariate logistic regression to assess independent relationships, high weight worry was significantly (p < 0.05) more common among respondents who were women, less educated, had type 2 diabetes and more comorbidities, were diagnosed more recently and reported weight gain with diabetes. Using multivariate logistic regression to control for confounding factors, high weight worry was significantly (p < 0.05) associated with most of the adverse outcomes examined, including lower self-rated health, poorer reported regimen adherence and diabetes control, more diabetes-related distress, poorer psychological well-being, and more psychological treatment. LIMITATIONS: The cross-sectional, correlational analysis could not assess causal relationships among patient reported outcomes, and the study did not include objective outcome measures.
CONCLUSIONS: High weight worry was common among adults with diabetes and associated with several adverse outcomes, including multiple indicators of diabetes-related distress, poor physical and psychological well-being, and regimen non-adherence. These findings suggest that healthcare providers should assess and address weight worry among their patients with diabetes.

Entities:  

Mesh:

Year:  2009        PMID: 19555311     DOI: 10.1185/03007990903073654

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  15 in total

1.  Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Authors:  Melanie J Davies; Divina Glah; Barrie Chubb; Gerasimos Konidaris; Phil McEwan
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

2.  The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump.

Authors:  Emmanouil S Benioudakis; Evangelos D Georgiou; Eirini D Barouxi; Athanasios M Armagos; Vaia Koutsoumani; Faidra Anastasiou-Veneti; Eleni Koutsoumani; Maria Brokalaki
Journal:  Diabetol Int       Date:  2020-11-16

3.  Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.

Authors:  M Peyrot; A H Barnett; L F Meneghini; P-M Schumm-Draeger
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

4.  Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework.

Authors:  Mark Peyrot; Richard R Rubin
Journal:  Patient Prefer Adherence       Date:  2011-06-07       Impact factor: 2.711

5.  Psychological barriers to optimal insulin therapy: more concerns in adolescent females than males.

Authors:  Line Wisting; Lasse Bang; Torild Skrivarhaug; Knut Dahl-Jørgensen; Øyvind Rø
Journal:  BMJ Open Diabetes Res Care       Date:  2016-06-23

6.  Barriers to achieving glycemic targets: who omits insulin and why?

Authors:  Katie Weinger; Elizabeth A Beverly
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

7.  Correlates of insulin injection omission.

Authors:  Mark Peyrot; Richard R Rubin; Davida F Kruger; Luther B Travis
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

8.  IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.

Authors:  Nick Freemantle; Muhammad Mamdani; Tina Vilsbøll; Jens Harald Kongsø; Kajsa Kvist; Stephen C Bain
Journal:  Diabetes Ther       Date:  2015-11-18       Impact factor: 2.945

9.  Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.

Authors:  Joshua J Neumiller
Journal:  Clin Diabetes       Date:  2014-10

Review 10.  Quality of life and psychological well-being in obesity management: improving the odds of success by managing distress.

Authors:  M Vallis
Journal:  Int J Clin Pract       Date:  2016-02-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.